Corteva, Inc. (BVMF:C1TV34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 277.53B +9.0% |
| Revenue (ttm) | 92.28B +3.7% |
| Net Income | 5.23B -28.0% |
| EPS | 7.76 -26.4% |
| Shares Out | n/a |
| PE Ratio | 53.09 |
| Forward PE | 20.87 |
| Dividend | 0.63 (0.61%) |
| Ex-Dividend Date | Aug 31, 2026 |
| Volume | 4 |
| Open | 103.99 |
| Previous Close | 106.30 |
| Day's Range | 103.50 - 103.99 |
| 52-Week Range | 80.00 - 115.51 |
| Beta | 0.58 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 4, 2026 |
About Corteva
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profit... [Read more]
Financial Performance
In 2025, Corteva's revenue was $17.40 billion, an increase of 2.92% compared to the previous year's $16.91 billion. Earnings were $1.09 billion, an increase of 20.62%.
Financial numbers in USD Financial StatementsNews
Argus positive on of improving fundamentals for Corteva
Argus analyst Alexandra Yates keeps a Buy rating and $91 price target on Corteva (CTVA). The firm is positive on the company’s combination of improving fundamentals and stabilizing prices, also…
Corteva price target raised to $91 from $86 at Citi
Citi raised the firm’s price target on Corteva (CTVA) to $91 from $86 and keeps a Neutral rating on the shares.
Corteva price target lowered to $95 from $100 at BMO Capital
BMO Capital lowered the firm’s price target on Corteva (CTVA) to $95 from $100 and keeps an Outperform rating on the shares. The firm is updating its model after the…
Corteva price target raised to $90 from $85 at UBS
UBS raised the firm’s price target on Corteva (CTVA) to $90 from $85 and keeps a Neutral rating on the shares.
Corteva sees FY29 revenue $8.4B-$8.7B
Sees FY29 operating EBITDA $1.45B-$1.65B. Comments taken from Investor Day 2026 presentation slides.
Corteva Transcript: Investor Day 2026
A focused crop protection strategy leverages a robust innovation pipeline, disciplined capital allocation, and operational excellence to drive 6% annual EBITDA growth and margin expansion through 2029. New products and biologicals are expected to offset pricing headwinds, while $500M in productivity gains and a strong balance sheet support continued investment and shareholder returns.
Corteva Slides: FY 2026
Corteva has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 15, 2026.
Corteva Transcript: Vylor Investor Day 2026
Vylor is transforming into a high-margin, IP-driven platform, launching 12 new technology platforms and targeting $2 billion in licensing revenue by 2040. Financial goals include 3%-4% annual sales growth, 7%-8% EBITDA growth, and 60%+ free cash flow conversion, supported by strong R&D and capital allocation discipline.
Corteva Slides: FY 2026
Corteva has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 15, 2026.
Corteva to launch hybrid wheat technology platform in 2027
Corteva (CTVA) confirmed progress of the hybrid wheat technology platform of Vylor, its advanced seed and genetics spin-off, with the announcement of Xpedite, the system used to create its proprietary...
Vylor to Expand Soybean Leadership: Next-Gen Tech Platforms Maintain North America Yield Advantage, Accelerate Latin America Lineup via Broad Spectrum Insect Control
Launch of New Platforms to Outpace Industry and Deliver ~$500M Incremental Revenue by 2035 INDIANAPOLIS, Sept. 15, 2026 /PRNewswire/ -- Ahead of its planned separation on October 1, 2026, Corteva, Inc...
Vylor Confirms Breakthrough Wheat Technology Will Launch in 2027
Company forecasts $500 million in NA wheat revenue by 2035, $1 billion by 2040 INDIANAPOLIS, Sept. 15, 2026 /PRNewswire/ -- Ahead of its planned separation on October 1, 2026, Corteva, Inc. (NYSE: CTV...
Corteva Categorically Rejects Unfounded, Unprecedented Allegations by State Attorneys General
Future crop protection company will be a strongly capitalized market leader with compelling value proposition for farmers, shareholders INDIANAPOLIS, Sept. 14, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE...
Corteva board approves Vylor distribution
Corteva (CTVA) announced that its Board of Directors has approved the previously announced separation of Corteva into two independent, publicly traded companies through the separation of Corteva’s see...
Corteva Board of Directors Approves Vylor Distribution
INDIANAPOLIS, Sept. 14, 2026 /PRNewswire/ -- Corteva (NYSE: CTVA) today announced that its Board of Directors has approved the previously announced separation of Corteva into two independent, publicly...
Corteva initiated with a Sector Weight at KeyBanc
KeyBanc initiated coverage of Corteva (CTVA) with a Sector Weight rating and no price target The firm rolled out coverage on 19 chemical and agriculture companies, with nine Overweights, nine…
Baron & Budd Secures $380 Million Settlement With DuPont, Chemours, and Corteva Over North Carolina PFAS Contamination
DALLAS--(BUSINESS WIRE)--Baron & Budd has secured a $380 million settlement with DuPont, The Chemours Company, and Corteva on behalf of 11 North Carolina public entities to resolve claims arising from...
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million
Chemours , DuPont and Corteva on Thursday reached a $455 million settlement with North Carolina and 11 local entities over PFAS contamination claims tied to Chemours' Fayetteville Works plant and ot...
DuPont Chemours and Corteva resolve PFAS-related claims in NC
DuPont (DD) announced that, together with Chemours (CC) and Corteva (CTVA) and its subsidiary EIDP, it has entered into a settlement with the State of North Carolina and 11 local…
Chemours, DuPont and Corteva resolve PFAS claims with $455M settlement
Chemours (CC) announced that, along with DuPont (DD) and Corteva (CTVA), it has entered into a settlement with the State of North Carolina and 11 local entities in the vicinity…
Corteva, Globachem to form joint venture
Corteva (CTVA) and Globachem N.V., a private company based in Belgium specializing in developing and globally marketing a wide range of crop protection products, announced that they have entered into…
Corteva, Globachem Enter into Definitive Agreement to Form a Joint Venture to Advance Development, Commercialization of New Formulated Crop Protection Solutions
JV to amplify both companies' complementary expertise to develop, scale, deliver differentiated crop protection solutions in high-growth markets INDIANAPOLIS and SINT-TRUIDEN, Belgium, Sept. 9, 2026 /...
Corteva’s Vylor announces launch of Vylor Edge
Vylor, the company that will spin-off from Corteva (CTVA) on October 1, 2026, announced the launch of Vylor Edge, a new investment platform made to help accelerate the development of…
Vylor Launches Vylor Edge, New Investment Platform for Global Agriculture Innovation
Platform to accelerate investment in next generation ag-tech innovation JOHNSTON, Iowa, Sept. 3, 2026 /PRNewswire/ -- Vylor, the advanced seed and genetics company that will spin-off from Corteva on ...
Vylor Launches a New Era in Corn: Industry-First Yield and Yield Stability Trait, Advanced Insect Control to Deliver Step-Change in Production, Farmer Profitability
Company to Lock in Market Leadership, Deliver $2 Billion in Incremental Revenue by 2035 INDIANAPOLIS, Sept. 1, 2026 /PRNewswire/ -- Ahead of its planned separation on October 1, 2026, Corteva, Inc. (N...